BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30819919)

  • 1. A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma.
    Lovisa F; Binatti A; Coppe A; Primerano S; Carraro E; Pillon M; Pizzi M; Guzzardo V; Buffardi S; Porta F; Farruggia P; De Santis R; Bulian P; Basso G; Lazzari E; d'Amore ESG; Bortoluzzi S; Mussolin L
    Haematologica; 2019 Sep; 104(9):e406-e409. PubMed ID: 30819919
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations of
    Schmidt J; Ramis-Zaldivar JE; Nadeu F; Gonzalez-Farre B; Navarro A; Egan C; Montes-Mojarro IA; Marafioti T; Cabeçadas J; van der Walt J; Dojcinov S; Rosenwald A; Ott G; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2017 Jul; 130(3):323-327. PubMed ID: 28533310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
    Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
    Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.
    Schmidt J; Gong S; Marafioti T; Mankel B; Gonzalez-Farre B; Balagué O; Mozos A; Cabeçadas J; van der Walt J; Hoehn D; Rosenwald A; Ott G; Dojcinov S; Egan C; Nadeu F; Ramis-Zaldívar JE; Clot G; Bárcena C; Pérez-Alonso V; Endris V; Penzel R; Lome-Maldonado C; Bonzheim I; Fend F; Campo E; Jaffe ES; Salaverria I; Quintanilla-Martinez L
    Blood; 2016 Aug; 128(8):1101-11. PubMed ID: 27257180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
    Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
    Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
    Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
    Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
    Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
    Launay E; Pangault C; Bertrand P; Jardin F; Lamy T; Tilly H; Tarte K; Bastard C; Fest T
    Leukemia; 2012 Mar; 26(3):559-62. PubMed ID: 21941365
    [No Abstract]   [Full Text] [Related]  

  • 9. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
    Salaverria I; Martin-Guerrero I; Burkhardt B; Kreuz M; Zenz T; Oschlies I; Arnold N; Baudis M; Bens S; García-Orad A; Lisfeld J; Schwaenen C; Szczepanowski M; Wessendorf S; Pfreundschuh M; Trümper L; Klapper W; Siebert R
    Genes Chromosomes Cancer; 2013 Feb; 52(2):150-5. PubMed ID: 23073988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes.
    Naresh KN
    Haematologica; 2007 Feb; 92(2):267-8. PubMed ID: 17296585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing.
    Zamò A; Pischimarov J; Schlesner M; Rosenstiel P; Bomben R; Horn H; Grieb T; Nedeva T; López C; Haake A; Richter J; Trümper L; Lawerenz C; Klapper W; Möller P; Hummel M; Lenze D; Szczepanowski M; Flossbach L; Schreder M; Gattei V; Ott G; Siebert R; Rosenwald A; Leich E
    Leukemia; 2018 Mar; 32(3):685-693. PubMed ID: 28824170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
    van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
    Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion.
    Zamò A; Pischimarov J; Horn H; Ott G; Rosenwald A; Leich E
    Br J Haematol; 2018 Feb; 180(3):391-394. PubMed ID: 29193015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
    Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M; Matheson E; Minto L; Hassan R; Harrison CJ; Bown N; Bailey S; Vormoor J; Hall AG; Irving JA
    Cancer Res; 2008 Aug; 68(16):6803-9. PubMed ID: 18701506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT
    Belman JP; Meng W; Wang HY; Li J; Strauser HT; Rosenfeld AM; Zhang Q; Prak ETL; Wasik M
    Cold Spring Harb Mol Case Stud; 2020 Feb; 6(1):. PubMed ID: 31776129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
    Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
    Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
    Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
    Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.